Status:

RECRUITING

Movement Behaviours Among Bahraini Diabetics

Lead Sponsor:

Royal College of Surgeons in Ireland - Medical University of Bahrain

Collaborating Sponsors:

Ministry of Health, Bahrain

Arabian Gulf University, Bahrain

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

20-75 years

Brief Summary

This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes. The main objectives are: (i) Measure free-living phys...

Detailed Description

In Bahrain, the number of people diagnosed with diabetes has risen from 9% at the start of the new millennium to 15% in 2022, and like any other country, it places a significant burden on the country'...

Eligibility Criteria

Inclusion

  • Sex: Men and women are eligible.
  • Age: Individuals aged 20-75 years old are eligible.
  • Ethnicity: Bahraini adults of all ethnic groups are eligible for the study.
  • Type 2 diabetes and glycaemic control: Individuals with controlled type 2 diabetes (i.e. HbA1c \<9 on medication) based on the medical record of each patient's last visit to the health centre for routine follow-up will be eligible if within the last four months. Otherwise, these measurements will be ordered at the first visit to confirm eligibility.
  • Blood pressure: Individuals whose blood pressure is under moderate control will be eligible - specifically, treated or untreated resting systolic/diastolic pressure \< 160/100 mmHg.
  • Lipid control: Individuals with fasting triglyceride concentration \< 600 mg are eligible.

Exclusion

  • HbA1c \>9%
  • Type 1 diabetes
  • Taking insulin
  • Pregnancy
  • Non-ambulant or severely incapacitated with any medical condition(s) reducing ability to stand or mobilize.
  • Currently participating in a study to reduce sedentary behaviour or increase physical activity
  • Language. Inability to read and understand Arabic or English language.
  • Inability to give informed consent.

Key Trial Info

Start Date :

April 24 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

340 Patients enrolled

Trial Details

Trial ID

NCT06069258

Start Date

April 24 2024

End Date

December 31 2025

Last Update

February 26 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Isa Town Health Centre

Building 10, Road 43, Manama, Bahrain, Block 743

2

Ahmed Ali Kanoo Health Centre

Building 2009, Road 2641, Manama, Bahrain, Block 626

3

Halat Bu Maher Health Centre

Building 2858, Road 1653, Muharraq, Bahrain, Block 216

4

Shaikh Jaber AlSabah Health Centre

Building 6347, Road Nakheel Street, Northern Governorate, Bahrain, Block 518